N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide

C41H39BrN6O4 — CID 23958056

IUPACN-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide
SMILESC[C@H](/C=C/CCn1cc(C(CO)c2ccccc2)nn1)[C@@]1(O)C(=O)N(Cc2ccc(NC(=O)Cc3c[nH]c4ccccc34)cc2)c2ccc(Br)cc21
InChIInChI=1S/C41H39BrN6O4/c1-27(9-7-8-20-47-25-37(45-46-47)34(26-49)29-10-3-2-4-11-29)41(52)35-22-31(42)16-19-38(35)48(40(41)51)24-28-14-17-32(18-15-28)44-39(50)21-30-23-43-36-13-6-5-12-33(30)36/h2-7,9-19,22-23,25,27,34,43,49,52H,8,20-21,24,26H2,1H3,(H,44,50)/b9-7+/t27-,34?,41+/m1/s1
InChIKeyNQAQRWPDPDAKFJ-ZJYBRPKKSA-N
MW759.71 g/mol
LogP6.84
Rot. Bonds13

About N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide

N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide (PubChem CID 23958056) has the molecular formula C41H39BrN6O4 and a molecular weight of 759.71 g/mol. Its IUPAC name is N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide.

Molecular Properties

Compound NameN-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide
PubChem CID23958056
Molecular FormulaC41H39BrN6O4
Molecular Weight759.71 g/mol
Exact Mass758.22
IUPAC NameN-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide
SMILESC[C@H](/C=C/CCn1cc(C(CO)c2ccccc2)nn1)[C@@]1(O)C(=O)N(Cc2ccc(NC(=O)Cc3c[nH]c4ccccc34)cc2)c2ccc(Br)cc21
InChIInChI=1S/C41H39BrN6O4/c1-27(9-7-8-20-47-25-37(45-46-47)34(26-49)29-10-3-2-4-11-29)41(52)35-22-31(42)16-19-38(35)48(40(41)51)24-28-14-17-32(18-15-28)44-39(50)21-30-23-43-36-13-6-5-12-33(30)36/h2-7,9-19,22-23,25,27,34,43,49,52H,8,20-21,24,26H2,1H3,(H,44,50)/b9-7+/t27-,34?,41+/m1/s1
InChIKeyNQAQRWPDPDAKFJ-ZJYBRPKKSA-N
XLogP6.84
TPSA136.37 Ų
H-Bond Donors4
H-Bond Acceptors7
Rotatable Bonds13
Heavy Atoms52
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500759.71
LogP ≤ 56.84
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide?
The IUPAC name of N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide (CID 23958056) is N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide.
What is the SMILES notation for N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide?
The canonical SMILES for N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide is C[C@H](/C=C/CCn1cc(C(CO)c2ccccc2)nn1)[C@@]1(O)C(=O)N(Cc2ccc(NC(=O)Cc3c[nH]c4ccccc34)cc2)c2ccc(Br)cc21.
What is the InChIKey of N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide?
The InChIKey is NQAQRWPDPDAKFJ-ZJYBRPKKSA-N. The full InChI is InChI=1S/C41H39BrN6O4/c1-27(9-7-8-20-47-25-37(45-46-47)34(26-49)29-10-3-2-4-11-29)41(52)35-22-31(42)16-19-38(35)48(40(41)51)24-28-14-17-32(18-15-28)44-39(50)21-30-23-43-36-13-6-5-12-33(30)36/h2-7,9-19,22-23,25,27,34,43,49,52H,8,20-21,24,26H2,1H3,(H,44,50)/b9-7+/t27-,34?,41+/m1/s1.
What are the key properties of N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide?
N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide has a molecular weight of 759.71 g/mol, XLogP of 6.84, 13 rotatable bonds, 4 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[[(3S)-5-bromo-3-hydroxy-3-[(E,2R)-6-[4-(2-hydroxy-1-phenylethyl)triazol-1-yl]hex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide is sourced from PubChem (CID 23958056), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).